Reliability of the fagerstrom tolerance questionnaire and the fagerstrom test for nicotine dependence

doi:10.1016/0306-4603(94)90049-3

Addictive Behaviors

Volume 19, Issue 1, January–February 1994, Pages 33-39

https://doi.org/10.1016/0306-4603(94)90049-3 Get rights and content

Abstract

The purpose of this study was to assess the test-retest stability of the Fagerstrom Tolerance Questionnaire (FTQ) in two samples: (a) paid subjects in an American laboratory; data were collected via telephone screen and subsequently via questions embedded in a written history; and (b) smokers hospitalized for depression in Paris; data were collected via a written questionnaire upon admission and again after 3 weeks of treatment for depression. Reliability data are also presented for a recently revised version of the FTQ, the Fagerstrom Test for Nicotine Dependence (FTND), and compared with FTQ data collected in a subsample of subjects in the American database who received both versions of the questionnaire. Both the FTQ (in both samples) and the FTND proved to be higly reliable. The validity of the scales, using cotinine, number of years smoked, and the “addictive” factor on the Classification of Smoking by Motives questionnaire as criterion variables, was also supported. No relationship between FTQ score and severity of depression was detected in either sample. Internal consistency was somewhat higher for the FTND than for the FTQ, replicating previous findings in the literature.

References (25)

K.O. Fagerstrom
Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment
Addictive Behaviors
(1978)
E. Lichtenstein et al.
Some methodological cautions in the use of the tolerance questionnaire
Addictive Behaviors
(1986)
T.W. Lombardo et al.
Failure to support the validity of the Fagerstrom Tolerance Questionnaire as a measure of physiological tolerance to nicotine
Addictive Behaviors
(1988)
B.L. Moore et al.
Fagerstrom's Tolerance Questionnaire: Clarification of item and scoring ambiguities
Addictive Behaviors
(1987)
R.P. Pinto et al.
Nicotine dependence and likelihood of quitting smoking
Addictive Behaviors
(1987)
C.S. Pomerleau et al.
Nicotine dependence and the Fagerstrom Tolerance Questionnaire: A brief review
Journal of Substance Abuse
(1989)
C.S. Pomerleau et al.
Relationship between Nicotine Tolerance Questionnaire scores and plasma cotine
Addictive Behaviors
(1990)
O.F. Pomerleau et al.
Nicotine dependence in cigarette smoking: An empirically based, multivariate model
Pharmacology Biochemistry & Behavior
(1983)
K.O. Fagerstrom
Effects of a nicotine-enriched cigarette on nicotine titration, daily cigarette consumption, and levels of carbon monoxide, cotinine, and nicotine
Psychopharmacology
(1982)
K.O. Fagerstrom et al.
Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire
Journal of Behavioral Medicine
(1989)

A.H. Glassman et al.

Smoking, smoking cessation, and major depression

JAMA

(1990)

M. Hamilton

Development of a rating scale for primary depressive illness

British Journal of Social and Clinical Psychology

(1967)

Cited by (604)

The effectiveness of a transtheoretical model-based smoking cessation intervention for rural smokers: A quasi-experimental longitudinal study
2024, Patient Education and Counseling
Cigarette smoking is highly prevalent, despite being a primary preventable cause of disease and mortality. This study examined the effect of a Transtheoretical Model (TTM)-based psychoeducational intervention for smoking cessation (SC) on knowledge, SC-related parameters, and progression through the TTM stages of change among rural smokers.
This quasi-experimental study recruited 200 smokers from an outpatient clinic. The comparison group was recruited before the experimental group to address possible self-selection bias. Structured questionnaires were administered pre- and post-intervention (three months) and at follow-up (six months).
A generalised estimation equation model indicated that the TTM-based intervention significantly increased participants’ SC-knowledge and improved progression through TTM stages by the six-month follow-up. No significant group differences were found in self-efficacy and nicotine dependence scores or daily cigarette consumption.
A TTM-based intervention enhances SC-knowledge and fosters progress through change stages. However, it does not directly impact nicotine dependence or cigarette consumption. Outpatient settings may employ TTM-based programmes for SC education and motivation. Detecting anticipated effects may require a longer intervention duration exceeding six months.
Such TTM-based programmes may facilitate SC-knowledge and motivation in outpatient settings. Further research to comprehend patients’ context and experiences during the stages of change is required.
Anxiety sensitivity and reasons for smoking among Black smokers
2023, Addictive Behaviors
Black smokers demonstrate higher nicotine dependence and experience higher rates of smoking-related diseases and mortality relative to European American/White smokers. A potential factor relevant to race-specific smoking health disparities may be smoking motives (i.e., motivational basis of smoking). Yet, little research has been conducted to understand psychological factors that may be associated with specific smoking motives among Black smokers. To address this gap in the literature, the current study explored the association between anxiety sensitivity and smoking motives within a subset sample of Black smokers who were interested in participating in a smoking cessation trial (N = 105; 70.5 % male; M_age = 44.8 years, SD = 11.6 years). Hierarchical regression analyses indicated anxiety sensitivity was associated with smoking motives related to habit (β = 0.39, p <.001), negative affect reduction (β = 0.32, p <.001), stimulation (β = 0.31, p <.001), and sensorimotor manipulation (β = 0.26, p =.008). Limited support was found for the effect of motives on past quit attempt engagement. These results may broaden understanding of the psychological mechanisms related to smoking motivation among Black smokers and may inform future intervention efforts to reduce smoking motivation among this health disparities population.
Cumulative vulnerabilities and smoking abstinence: A test from a randomized clinical trial
2023, Behaviour Research and Therapy
Smoking cessation is often associated with socioeconomic and intrapersonal vulnerabilities such as psychopathology. Yet, most research that focuses on predicting smoking cessation outcomes tends focus on a small number of possible vulnerabilities. In a secondary data analysis, we developed and empirically evaluated a comprehensive, cumulative vulnerability risk composite reflecting psychologically based transdiagnostic processes, social determinants of health, and psychopathology. Participants were adult smokers who responded to study advertisements (e.g., flyers, newspaper ads, radio announcements) for an in-person delivered 4-session smoking cessation trial (N = 267; 47% female; M_age = 39.4, SD = 13.8). Results indicated that the decline in point prevalence abstinence (PPA) from quit week to 6-month post-quit was statistically significant (p < .001). There were statistically significant effects of cumulative risk score on the intercept (p < .001) and slope (p = .01). These findings were evident in unadjusted and adjusted (controlling for sex, treatment condition, and nicotine dependence) models. The present results indicate smokers with greater cumulative vulnerability demonstrated poorer smoking cessation outcomes. There may be clinical advantages to better understanding cumulative vulnerability among treatment-seeking smokers and other smoking populations to enhance the impact of public health efforts to reduce smoking.
Difficulties in emotion regulation and ad libitum smoking topography: A secondary analysis
2023, Addictive Behaviors
Despite the well-known linkages between poor emotion regulation and subjective smoking motives, little is known about the role of emotion regulation in predicting smoking reinforcement behavior. This study examined the relation between difficulties in emotion regulation and puff velocity data, a behavioral index of smoking reinforcement, in adult daily cigarette smokers.
The current study was a secondary analysis of data collected from non-treatment seeking daily smokers (N = 124). Participants completed the Difficulties in Emotion Regulation Scale (DERS) followed by an ad libitum smoking period during which puff topography data was collected via a handheld puffing device. Puff velocity served as our puff topography index and was examined at the average and puff-to-puff level using regression and multi-level models, respectively.
Regression analyses showed no significant association between DERS scores and average puff velocity. In contrast, multi-level modeling found a significant quadratic time × DERS effect at the puff-to-puff level, such that those with greater emotion regulation difficulties inhaled more quickly at the initiation of the cigarette, whereas those with lower emotion regulation difficulties evidenced consistent puffing over the course of the cigarette.
Smokers with greater difficulties in emotion regulation appear to smoke in a way that maximizes delivery of nicotine, perhaps to self-regulate distress. One’s style of puffing may reflect a possible behavioral marker of negative reinforcement smoking, especially in the context of emotional distress.
This study was the first to explore the relationship between difficulties in emotion regulation and a behavioral measure of smoking reinforcement.
Approach bias retraining to augment smoking cessation: A pilot randomized controlled trial
2022, Drug and Alcohol Dependence
Approach tendency to smoking-related cues has been associated with greater cravings, nicotine dependence, and the likelihood of relapse. In this pilot randomized clinical trial, we examined the efficacy of approach bias retraining (ABR; i.e., increasing avoidance tendency) for enhancing standard smoking cessation treatment (ST).
Adult smokers (N = 96) motivated to quit were randomly assigned to 7 weekly in-person treatment sessions consisting of either (1) cognitive-behavioral therapy for smoking cessation (ST) and ABR (ST+ABR) or ST and sham retraining (ST+Sham). All participants also received optional nicotine replacement therapy for up to 8 weeks following the scheduled quit date (week 6). We measured avoidance tendency from weeks 1–7. Point prevalence abstinence (PPA) and prolonged abstinence (PA) were measured up to 3 months following the quit attempt (week 18 follow-up).
Consistent with our hypothesis, participants in ST+ABR evidenced higher abstinence rates than those in ST+Sham at the final follow-up (b=0.71, 95 % CI: [0.14, 1.27], t[1721]=2.46, p = 0.014, OR=2.03, 95 % CI: [1.15, 3.57]). Specifically, PPA and PA rates were 50 % and 66 % in ST+ABR compared to 31 % and 47 % in ST+Sham. As expected, participants assigned to the ST+ABR condition also showed a greater training-compatible increase in avoidance tendency scores relative to those assigned to the ST+Sham condition (b=248.06, 95 % CI: [148.51, 347,62], t[84]=4.96, p < .001).
The current pilot randomized clinical trial provides initial evidence for the efficacy of integrating standard smoking cessation with ABR. These findings encourage the testing of the long-term efficacy and mechanisms of action of this integrated intervention.
Associations of tobacco cigarette use and dependence with substance use disorder treatment completion by sex/gender and race/ethnicity
2022, Journal of Substance Abuse Treatment
Individuals with substance use disorders (SUD) are approximately five times more likely to smoke cigarettes than the general population. Individuals who smoke cigarettes have greater odds of SUD relapse compared to individuals who do not smoke cigarettes, but we know little about how cigarette use is related to SUD treatment completion overall by sex/gender or race/ethnicity.
This study examined 2855 adults (71.98 % male; >70 % racial/ethnic minority) in outpatient and residential SUD treatment at a New York–based treatment agency over a six-month period in 2018.
Overall, approximately three-fourths of SUD treatment-seeking participants smoked cigarettes, with high rates across sex/gender and racial/ethnic groups. Nicotine dependence did not differ by sex/gender, and White Non-Hispanic adults had the highest levels of nicotine dependence across racial/ethnic groups. Those who smoked cigarettes were significantly less likely to complete treatment compared to those who did not smoke cigarettes (OR = 0.69; 95 % CI: 0.58, 0.82). The study found no overall differences in SUD treatment completion and length of stay by sex/gender or race/ethnicity.
Given the high prevalence of cigarette smoking and lower odds of completing SUD treatment, the current system of care for SUD treatment may be enhanced by addressing cigarette smoking from onset of treatment.

View all citing articles on Scopus

^☆: Preparation of this manuscript was supported by Grant DA 06529 to the last author from the National Institute on Drug Abuse.

View full text

Reliability of the fagerstrom tolerance questionnaire and the fagerstrom test for nicotine dependence☆

Abstract

Addictive Behaviors

Addictive Behaviors

Addictive Behaviors

Addictive Behaviors

Addictive Behaviors

Journal of Substance Abuse

Addictive Behaviors

Pharmacology Biochemistry & Behavior

Effects of a nicotine-enriched cigarette on nicotine titration, daily cigarette consumption, and levels of carbon monoxide, cotinine, and nicotine

Psychopharmacology

Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire

Journal of Behavioral Medicine

Smoking, smoking cessation, and major depression

JAMA

Development of a rating scale for primary depressive illness

British Journal of Social and Clinical Psychology